Position in PBH
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$9,312,858
+$3,282,661 QoQ
Shares Held
157,126
+60.7% QoQ
Ownership
0.332%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PBH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ROYCE & ASSOCIATES LP holds $70,326,489 across 14 Drug Manufacturers - Specialty & Generic names. PBH ranks #3 (13.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SUPN |
Supernus Pharmaceuticals, Inc.
|
229,939 | $11,885,546 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
469,916 | $11,245,089 | |
| 3 | PBH |
Prestige Consumer Healthcare Inc.
This page
|
157,126 | $9,312,858 | |
| 4 | COLL |
Collegium Pharmaceutical, Inc
|
272,786 | $9,021,033 | |
| 5 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
406,175 | $7,956,968 | |
| 6 | ESPR |
Esperion Therapeutics, Inc.
|
2,626,995 | $7,197,966 | |
| 7 | SIGA |
Siga Technologies Inc
|
667,646 | $3,571,906 | |
| 8 | TKNO |
Alpha Teknova, Inc.
|
1,069,162 | $3,089,878 |
All Filings in PBH
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,312,858 | 157,126 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $6,030,197 | 97,750 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $3,623,256 | 58,065 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $4,625,630 | 57,929 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $4,991,848 | 58,065 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $4,534,295 | 58,065 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $4,196,220 | 58,200 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $4,007,070 | 58,200 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $4,222,992 | 58,200 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,580,574 | 58,487 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $3,344,871 | 58,487 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $3,467,265 | 58,342 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $3,655,838 | 58,372 | Shares | Sole | 2023-05-23 | |
| 2022-12-31 | $3,663,289 | 58,519 | Shares | Sole | 2023-05-23 | |
| 2022-09-30 | $3,150,451 | 63,224 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $3,949,302 | 67,165 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $3,859,378 | 72,901 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $517,587 | 8,534 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $534,559 | 9,527 | Shares | Sole | 2021-11-10 | |
| 2020-06-30 | $50,217 | 1,337 | Shares | Sole | 2020-08-07 | |
| No filing history on record for this holder in this stock. | ||||||